Alzamend Neuro(DE:9ZT)
€194.400.00 (0.00%)
DE:9ZT
Alzamend Neuro financials statements
€194.40
At close:0.00 (0.00%)
Alzamend Neuro (9ZT) Income Statement
2 Followers
Alzamend Neuro Income Statement
Last quarter (Q1 2027), Alzamend Neuro's total revenue was $0.00. In Q1, Alzamend Neuro's net income was $-3.03M. See Alzamend Neuro’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Apr 26 | Apr 25 | Apr 24 | Apr 23 | Apr 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 8.77M | $ 4.50M | $ 9.94M | $ 14.87M | $ 12.32M | |
| Depreciation and Amortization | $ 110.74K | $ 50.74K | $ 50.74K | $ 23.07K | $ 3.55K |
| $ -8.66M | $ -4.45M | $ -9.89M | $ -14.85M | $ -12.31M | |
| $ -8.77M | $ -4.50M | $ -9.94M | $ -14.87M | $ -12.32M | |
| $ -5.54K | $ -18.03K | $ -10.10K | $ -7.70K | $ -42.52K | |
| $ -8.77M | $ -4.51M | $ -9.95M | $ -14.88M | $ -12.36M | |
| $ -8.77M | $ -4.51M | $ -9.95M | $ -14.88M | $ -12.36M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.63 | $ -11.32 | $ -132.33 | $ -205.97 | $ -187.31 |
| Diluted EPS | $ -2.63 | $ -11.32 | $ -132.33 | $ -205.97 | $ -187.31 |
| Weighted Average Shares Outstanding | 3.34M | 398.00K | 75.00K | 72.00K | 65.00K |
| Weighted Average Shares Outstanding (Diluted) | 3.34M | 450.80K | 75.17K | 72.24K | 66.00K |
Currency in USD
